Alyeska Investment Group, L.P. Wave Life Sciences Ltd. Transaction History
Alyeska Investment Group, L.P.
- $18 Billion
- Q3 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 125,000 shares of WVE stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
125,000Holding current value
$1.41 Million% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding WVE
# of Institutions
165Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$205 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$113 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$109 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$75.9 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$69.5 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $978M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...